178 related articles for article (PubMed ID: 5697613)
1. Systemic and coronary hemodynamic effects of vasopressin.
Corliss RJ; McKenna DH; Sialer S; O'Brien GS; Rowe GG
Am J Med Sci; 1968 Nov; 256(5):293-9. PubMed ID: 5697613
[No Abstract] [Full Text] [Related]
2. Cardiovascular actions of vasopressin.
Nakano J
Jpn Circ J; 1973 Apr; 37(4):363-81. PubMed ID: 4580582
[No Abstract] [Full Text] [Related]
3. [Effects of octapressin on the general and coronary circulation in anesthetized, closed chest dogs].
Strauer BE; Reploh HD; Cott L; Tauchert M; Bretschneider HJ
Arztl Forsch; 1969 Jul; 23(7):227-35. PubMed ID: 5820305
[No Abstract] [Full Text] [Related]
4. Studies on the cardiovascular effects of synthetic vasopressin.
Nakano J
J Pharmacol Exp Ther; 1967 Jul; 157(1):19-31. PubMed ID: 6029485
[No Abstract] [Full Text] [Related]
5. [Effect of POR-8 (ornithine-vasopressin) on the coronary circulation].
Yusa T; Nishioka K; Iwatsuki K
Masui; 1971 Jul; 20(7):598-604. PubMed ID: 5105396
[No Abstract] [Full Text] [Related]
6. Systemic and coronary hemodynamic effects of glucagon.
Rowe GG
Am J Cardiol; 1970 Jun; 25(6):670-4. PubMed ID: 5420906
[No Abstract] [Full Text] [Related]
7. Systemic and coronary hemodynamic effects of diazepam in patients with normal and diseased coronary arteries.
Côté P; Guéret P; Bourassa MG
Circulation; 1974 Dec; 50(6):1210-6. PubMed ID: 4430116
[No Abstract] [Full Text] [Related]
8. Some cardiovascular effects of ornithine-8-vasopressin: a new surgical vasoconstrictor agent.
Coleman AJ; Baker LW
Br J Anaesth; 1973 May; 45(5):511-4. PubMed ID: 4715602
[No Abstract] [Full Text] [Related]
9. Effect of endotoxin on myocardial performance.
Hinshaw LB; Archer LT; Greenfield LJ; Miller JA; Guenter CA
J Trauma; 1972 Dec; 12(12):1056-62. PubMed ID: 4568504
[No Abstract] [Full Text] [Related]
10. The systemic and coronary hemodynamic effects of lidoflazine.
Thomsen JH; Stenlund RR; Corliss RJ; Sialer S; Rowe GG
Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):15-23. PubMed ID: 5650324
[No Abstract] [Full Text] [Related]
11. [Action of sodium cyanide on cardiac metabolism and systemic, pulmonary and coronary hemodynamics].
Laubie M; Schmitt H; Peltier J; Drouillat M
Arch Int Pharmacodyn Ther; 1966 Jan; 159(1):206-18. PubMed ID: 5918762
[No Abstract] [Full Text] [Related]
12. Hemodynamic activity of L 6150. Systemic and coronary circulation.
Sardi A; Caravaggi AM; Baldoli E
Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(3):301-12. PubMed ID: 4270747
[No Abstract] [Full Text] [Related]
13. Coronary and systemic haemodynamic effects of prostaglandins in the unanaesthetized dog.
Bloor CM; White FC; Sobel BE
Cardiovasc Res; 1973 Mar; 7(2):156-66. PubMed ID: 4694100
[No Abstract] [Full Text] [Related]
14. Effects of vasopressin on the circulation, myocardial dynamics, and left ventricular oxygen consumption in the anaesthetized dog.
Cartheuser CF; Komarek J
Basic Res Cardiol; 1980; 75(5):668-82. PubMed ID: 7447900
[No Abstract] [Full Text] [Related]
15. The cardiovascular effects of octapressin.
Maxwell GM
Arch Int Pharmacodyn Ther; 1965 Nov; 158(1):17-23. PubMed ID: 5854045
[No Abstract] [Full Text] [Related]
16. [Effects of 1-(beta-naphthyl)nonyl-1-amine on respiration and the cardiovascular system].
Pham-Huu-Chanh ; Buu-Hoï NP; Richert MT
Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):276-83. PubMed ID: 5481483
[No Abstract] [Full Text] [Related]
17. Systemic and coronary hemodynamic effects of isoproterenol in control animals and those pretreated with a MAO inhibitor (pargyline hydrochloride).
McKenna DH; Afonso S; Jaramillo CV; Crumpton CW; Rowe GG
Arch Int Pharmacodyn Ther; 1966 Aug; 162(2):275-82. PubMed ID: 5968511
[No Abstract] [Full Text] [Related]
18. [Animal experiment study on the coronary and circulatory effect of dipyridamole, carbocromen, hexobendine, dilazep and glucagon].
Reploh HD
Arzneimittelforschung; 1973 May; 23(5):629-39. PubMed ID: 4740201
[No Abstract] [Full Text] [Related]
19. [Change in systemic hemodynamics under the influence of vasopressin in dogs during ontogenesis].
Brin VB
Biull Eksp Biol Med; 1977 Mar; 83(3):261-3. PubMed ID: 851627
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of impaired cardiac function by vasopressin.
Wilson MF; Brackett DJ; Archer LT; Hinshaw LB
Ann Surg; 1980 Apr; 191(4):494-500. PubMed ID: 7369815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
